TY - CHAP
T1 - The Progression of Non-alcoholic Fatty Liver Disease and Lifestyle Intervention in Older Adults
AU - Jia, Xiaofang
AU - Naito, Hisao
AU - Kitamori, Kazuya
AU - Yetti, Husna
AU - Nakajima, Tamie
PY - 2015/1/27
Y1 - 2015/1/27
N2 - Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. It encompasses a spectrum of liver histology in individuals who drink little or no alcohol, ranging from simple fatty liver (steatosis), through fat accompanied by signs of hepatocyte injury, mixed inflammatory cell infiltrate, and variable hepatic fibrosis (non-alcoholic steatohepatitis, NASH), to cirrhosis and hepatocellular carcinoma. Approximately 19.0% of the general United States population has NAFLD, and around 11.8% of NAFLD patients develop NASH. The prevalence, severity, and progression of NAFLD/NASH are significantly associated with the presence of metabolic syndrome components, especially obesity and diabetes, and are also governed by the interactive effects of age, sex, genetic susceptibility, and lifestyle (diet and exercise). In particular, advanced age is associated with disease severity and fibrosis progression. A combination of dietary modification and physical activity is the cornerstone of NAFLD management, as there is a lack of efficacious and safe pharmacotherapy for this disease.
AB - Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. It encompasses a spectrum of liver histology in individuals who drink little or no alcohol, ranging from simple fatty liver (steatosis), through fat accompanied by signs of hepatocyte injury, mixed inflammatory cell infiltrate, and variable hepatic fibrosis (non-alcoholic steatohepatitis, NASH), to cirrhosis and hepatocellular carcinoma. Approximately 19.0% of the general United States population has NAFLD, and around 11.8% of NAFLD patients develop NASH. The prevalence, severity, and progression of NAFLD/NASH are significantly associated with the presence of metabolic syndrome components, especially obesity and diabetes, and are also governed by the interactive effects of age, sex, genetic susceptibility, and lifestyle (diet and exercise). In particular, advanced age is associated with disease severity and fibrosis progression. A combination of dietary modification and physical activity is the cornerstone of NAFLD management, as there is a lack of efficacious and safe pharmacotherapy for this disease.
UR - http://www.scopus.com/inward/record.url?scp=84944556089&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84944556089&partnerID=8YFLogxK
U2 - 10.1016/B978-0-12-418680-4.00009-9
DO - 10.1016/B978-0-12-418680-4.00009-9
M3 - Chapter
AN - SCOPUS:84944556089
SN - 9780124186804
SP - 85
EP - 97
BT - Foods and Dietary Supplements in the Prevention and Treatment of Disease in Older Adults
PB - Elsevier Inc.
ER -